S.Korea stocks hit 6-week high as Omicron concerns wane



* KOSPI rises, foreigners net buyers

* Korean won strengthens against U.S. dollar

* South Korea benchmark bond yield falls

SEOUL, Dec 8 (Reuters) - Round-up of South Korean financial markets:

** South Korean shares jumped on Wednesday to a six-week high, tracking Wall Street's overnight tech lead, as investors tempered fears about the impact of the Omicron variant despite a record jump in domestic coronavirus cases.

** The won strengthened, while the benchmark bond yield fell.

** By 0155 GMT, the benchmark KOSPI .KS11 was up 31.74 points, or 1.06%, at 3,023.46, after having gained as much as 1.48% to the highest intraday level since Oct. 27.

** Chip giant Samsung Electronics 005930.KS led benchmark gains with a 0.78% jump while battery maker LG Chem 051910.KS and platform company Naver 035420.KS added 4.64% and 1.28%, respectively.

** South Korean technology-related shares tracked a rally on Wall Street overnight after U.S. infectious disease official Anthony Fauci said the variant has a higher degree of transmissibility, but is seen less severe, according to preliminary evidence.

** Lifting market sentiment further was British drugmaker GSK's GSK.L statement that its antibody-based COVID-19 therapy is effective against all mutations of the new Omicron variant.

** South Korea reported a record 7,175 new virus cases for Tuesday even after it reimposed limits on private gatherings, while there are 38 confirmed cases of the Omicron variant so far.

** On the main board, foreigners were net buyers of 122.5 billion won ($104.19 million) worth of shares.

** The won was quoted at 1,175.6 per dollar on the onshore settlement platform KRW=KFTC , 0.33% higher than its previous close.

** In offshore trading, the won KRW= was quoted at 1,175.9, while in non-deliverable forward trading its one-month contract KRW1MNDFOR= was quoted at 1,176.1.

** In money and debt markets, December futures on three-year treasury bonds KTBc1 rose 0.12 point to 109.05.

** The benchmark 10-year yield fell by 4.5 basis points to 2.195%.

($1 = 1,175.7100 won)
Reporting by Joori Roh; Editing by Sherry Jacob-Phillips

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.